These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7169980

  • 1. Parathyroid hormone immunoreactivity in the plasma filtrate of uremic patients.
    Tsutsumi M, Fukase M, Fujita T, Fujita K, Inoue S, Shin J.
    Miner Electrolyte Metab; 1982 Mar; 7(3):146-50. PubMed ID: 7169980
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J.
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Parathyroid hormone-, 25-OH-vitamin D-, and digoxin levels in patients treated by chronic hemofiltration.
    Schaefer K, Offermann G, von Herrath D, Asmus G, Hüfler M.
    J Dial; 1977 May; 1(6):619-30. PubMed ID: 608871
    [Abstract] [Full Text] [Related]

  • 10. [The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration].
    Civati G, Guastoni C, Perego A, Galato R, Brando B, Grillo C, Surian M, Colussi G, Teatini U, Minetti L.
    Minerva Nefrol; 1981 May; 28(2):171-4. PubMed ID: 7290521
    [No Abstract] [Full Text] [Related]

  • 11. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H, Bergström J, Fürst P, Johnson C, Yahiel V.
    Artif Organs; 1981 May; 4 Suppl():137-42. PubMed ID: 7295080
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 May; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemical analytic approaches to the definition of uremic toxins.
    Furst P, Bergstrom J, Gordon A, Zimmermann L.
    Ateneo Parmense Acta Biomed; 1975 May; 46(5):307-16. PubMed ID: 1232992
    [Abstract] [Full Text] [Related]

  • 17. Analytical study for separation of middle molecules.
    Saito A, Kanazawa I, Chung TG, Maeda K.
    Artif Organs; 1981 May; 4 Suppl():13-6. PubMed ID: 6975092
    [Abstract] [Full Text] [Related]

  • 18. Fate of parathyroid hormone during hemodialysis and ultrafiltration.
    Burckhardt P, Jaeger P, Jacquet AF, Wauters JP.
    Horm Res; 1985 May; 21(1):46-54. PubMed ID: 3972336
    [Abstract] [Full Text] [Related]

  • 19. Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients.
    Schaefer K, Offermann G, von Herrath D, Schröter R, Stölzel R, Arntz HR.
    Clin Nephrol; 1980 Aug; 14(2):81-8. PubMed ID: 7408260
    [Abstract] [Full Text] [Related]

  • 20. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M, Frølich A, Haaber A, Tvedegaard E, Thode J.
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.